Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice.
about
Celiac disease: prevalence, diagnosis, pathogenesis and treatmentBetween celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivityAnimal models to study gluten sensitivityImmune development and intestinal microbiota in celiac diseaseParallels between pathogens and gluten peptides in celiac sprueReview article: coeliac disease, new approaches to therapy.The immune recognition of gluten in coeliac disease.Prevention measures and exploratory pharmacological treatments of celiac disease.Type-specific human papillomavirus detection in cervical smears in Romania.Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.Molecular mechanisms of the adaptive, innate and regulatory immune responses in the intestinal mucosa of celiac disease patients.Immunomodulatory strategies for celiac disease.Important lessons derived from animal models of celiac disease.Possible drug targets for celiac disease.What causes type 1 diabetes? Lessons from animal models.Pharmacotherapy and management strategies for coeliac disease.Experiences with animal models of dermatitis herpetiformis: a review.Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management.Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.Latest in vitro and in vivo models of celiac disease.Current status of drugs in development for celiac disease.Emerging drugs for coeliac disease.No genetic association of the human prolyl endopeptidase gene in the Dutch celiac disease population.Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/MpJ-FaslprmiceCross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity
P2860
Q22305490-E7C1C168-26F3-4ED4-B974-B8FFFE197048Q24623796-CB8B3CDD-79C7-4C41-83BD-F8467E797144Q26859130-F661824E-D360-4330-8668-A1B687E5CC2AQ27026098-6B001309-0AA7-4DDB-8315-4D8405CAF7AAQ33329537-EF95D313-6D26-4B52-B376-F4AEBF933BBCQ34253519-2B9753BE-3A34-4A6C-9D34-89EF08F47A10Q34423420-596E88DF-C20D-49F0-9E75-6E0DCB1FA33DQ34623902-DA6E8E14-C4D1-4726-89A9-FDA09602939EQ35094156-BD0EF956-495B-41DB-B534-4BA6AA46CE87Q36027518-0C94CF4F-2200-4C0C-BBB2-16510138C7B6Q36252174-80EF7817-D826-4221-8513-5FE677A40A2FQ36327386-29791317-1A8F-415D-8BEC-DE6EADDE6C92Q36344842-0DCF7054-0944-4FC1-82D0-D223969A305AQ36539486-76137A74-9ED2-4807-87D5-2E26004C3B03Q37880270-F3A2995C-D5F2-48A9-8033-5DFCF50EE86FQ37896092-5BEDF43B-F473-4D56-8A78-93A2848DDD0BQ37934991-AF471862-5375-477B-AED3-219800E27C4AQ37965669-BBAD4C67-81E0-48ED-A9BA-580DCE07C172Q38021639-FAAF8066-9A55-4845-BEA2-84EBFED84C24Q38072065-C021D06D-35F4-478A-B255-E9AE2FBC3A89Q38210088-8AC0EEB6-DC06-47D6-A1A3-35996DFB8CBEQ38248960-C92D2008-AEAA-49EC-A5E9-0D7399694989Q46487852-F1ED8C86-AD95-4332-868F-773BC5CF4AB1Q57600355-B78542D7-FF61-4350-9994-010627BC2907Q59137735-3616FC3C-A65F-4D6D-8748-CBA683B57224
P2860
Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Intranasal administration of a ...... liadin in DQ8 transgenic mice.
@en
Intranasal administration of a ...... liadin in DQ8 transgenic mice.
@nl
type
label
Intranasal administration of a ...... liadin in DQ8 transgenic mice.
@en
Intranasal administration of a ...... liadin in DQ8 transgenic mice.
@nl
prefLabel
Intranasal administration of a ...... liadin in DQ8 transgenic mice.
@en
Intranasal administration of a ...... liadin in DQ8 transgenic mice.
@nl
P2093
P50
P1433
P1476
Intranasal administration of a ...... gliadin in DQ8 transgenic mice
@en
P2093
Carmela Gianfrani
Chella David
Diomira Luongo
Maria F Mazzeo
Riccardo Troncone
Salvatore Auricchio
Stefania Senger
P304
P356
10.1016/S0165-2478(03)00069-5
P577
2003-08-01T00:00:00Z